Circulating IL-17 Level Is Positively Associated with Disease Activity in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

Yin, Rulan; Xu, Rong; Ding, Lei; Sui, Wenjie; Niu, Mei'e; Wang, Mingjun; Xu, Lan; Wang, Haifang; Srirat, Chomphoonut

Yin, Rulan; Xu, Rong; Ding, Lei; Sui, Wenjie; Niu, Mei'e; Wang, Mingjun; Xu, Lan; Wang, Haifang; Srirat, Chomphoonut.

Afiliação

Yin R; Department of Rheumatology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Xu R; Faculty of Nursing, Chiang Mai University, Chiangmai, Thailand.
Ding L; Department of Rheumatology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Sui W; Department of Internal Medicine, Suzhou Municipal Hospital, Suzhou, China.
Niu M; Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China.
Wang M; Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China.
Xu L; Department of Rheumatology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Wang H; Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China.
Srirat C; Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China.

Biomed Res Int ; 2021: 9952463, 2021.

Article em En | MEDLINE | ID: mdl-34337065

Assuntos

Interleucina-17/sangue; Lúpus Eritematoso Sistêmico/sangue; Lúpus Eritematoso Sistêmico/patologia; Adolescente; Adulto; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Viés de Publicação; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-17 / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials / Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Biomed Res Int Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google